New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 11, 2013
09:08 EDTSTEMStemCells enters agreement to receive $19.3M from CIRM for HuCNS-SC
StemCells announced that it has entered into an agreement with the California Institute for Regenerative Medicine, or CIRM, under which CIRM will provide approximately $19.3M to help fund preclinical development and IND-enabling activities of the company's proprietary HuCNS-SC product candidate for Alzheimer's disease. The funding, which will be in the form of a forgivable loan, was awarded under CIRM's Disease Team Therapy Development Award program in September 2012. The goal of the research will be to file an Investigational New Drug application with the FDA within four years.
News For STEM From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 26, 2015
10:04 EDTSTEMStemCells reports top line results for Phase I/II study in dry AMD
Subscribe for More Information
June 22, 2015
07:05 EDTSTEMStemCells data likely to be positive, says Cantor
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use